AI Summary Rapamune (sirolimus) is an oral mTOR inhibitor used as long-term maintenance therapy to help prevent organ rejection after liver transplantation.
Medically reviewed.
Rapamune (sirolimus) is an oral prescription immunosuppressive medication used to help prevent organ rejection after liver transplantation. It belongs to a class of medications called mammalian target of rapamycin (mTOR) inhibitors, which block cellular pathways that T-cells use to multiply. By calming this immune activity, Rapamune reduces immune-mediated injury to the transplanted liver. Providers may use it as an alternative to, or alongside, calcineurin inhibitors. Treatment decisions should always be individualized and guided by your transplant team.
This page covers Rapamune's role after liver transplant — how it works, who may be considered for it, how it is used, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Rapamune fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT RAPAMUNE TREATMENT
Rapamune is a prescription medicine that contains sirolimus. It belongs to a class of medications called mammalian target of rapamycin (mTOR) inhibitors. It is an immunosuppressive medication, which means it lowers the activity of your immune system so that your body does not attack the transplanted liver.
Rapamune is used to help prevent organ rejection after liver transplantation. It is available as oral tablets and as an oral solution. Everolimus (Zortress) belongs to the same mTOR inhibitor class and is also used after liver transplant.
Rapamune is typically part of long-term care that includes regular blood tests and follow-up visits with your transplant team. Other anti-rejection medicines, such as Prograf (Tacrolimus), belong to a different group called calcineurin inhibitors.
WHO RAPAMUNE MAY BE SUITABLE FOR
Your healthcare provider may prescribe Rapamune if you have received a liver transplant and need long-term immunosuppressive therapy. It may be chosen when you need an alternative or add-on to calcineurin inhibitors, or when your provider wants to lower the risk of organ rejection with a plan tailored to you.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Rapamune. Treatment decisions are individualized and should be made by your transplant team after a full assessment of your transplant, your health, and your other medications.
ELIGIBILITY OVERVIEW
Rapamune may be considered for adults with the following situations or treatment goals:
Before recommending Rapamune, your transplant team reviews your overall situation to decide whether it is an appropriate option. This includes:
HOW RAPAMUNE CAN HELP YOUR TRANSPLANTED LIVER
Rapamune blocks the mTOR pathway, a cell signal that helps immune cells become active. When this pathway is blocked, T-lymphocytes (T-cells), a type of white blood cell, cannot multiply as they normally would.
With fewer active T-cells, the immune system is less likely to attack the new liver. This reduces immune-mediated injury to the transplanted liver and helps prevent both acute and chronic rejection.
For people who have had a liver transplant, these effects support long-term graft survival, meaning the transplanted liver keeps working over time. Rapamune is not used on its own without supervision — your transplant team adjusts it based on sirolimus blood levels and monitors your health with regular tests.
TRANSPLANT BENEFITS
T-lymphocytes, also called T-cells, are white blood cells that help the immune system respond to anything it sees as foreign, including a transplanted organ. Rapamune inhibits the mTOR pathway, a cell signal involved in immune cell activation. With that signal blocked, T-cells cannot multiply as they normally would, so fewer of them are available to react against the new liver.
Damage caused when immune cells attack a transplanted organ is called immune-mediated injury. Because Rapamune lowers T-cell activity, it reduces this type of injury to the transplanted liver and helps protect the organ from the body's own defenses.
Rapamune is used to help prevent both acute rejection and chronic rejection. Both happen when the immune system reacts against the transplanted organ, which is why lowering T-cell activity matters for each.
Graft survival means that the transplanted liver keeps working over time. By limiting T-cell activity and the immune injury that follows, Rapamune supports this outcome.
Rapamune lowers immune activity to help protect a transplanted liver from rejection. It should only be started and monitored under the guidance of your transplant team.
TREATMENT PROCESS
Rapamune is available as oral tablets and as an oral solution. Take it exactly as prescribed, and check with your pharmacist if you have questions about the form you were given.
The typical maintenance dose ranges from 1-4 mg once daily. Your transplant team adjusts the dose based on your sirolimus blood levels and how you respond. Do not change your dose without medical guidance.
Rapamune is taken by mouth once daily, with or without food. Take it at the same time each day and keep the same routine, so your blood levels stay steady.
Rapamune is generally used as long-term maintenance therapy after liver transplantation. Treatment may continue for many years, or for life, if you tolerate it well and it remains appropriate. Do not stop taking it without first talking to your transplant team.
Store Rapamune at room temperature, away from moisture and heat.
Regular monitoring of sirolimus blood levels, liver function, kidney function, cholesterol levels, and blood counts is recommended. Report any side effects or unusual symptoms to your transplant team.
BENEFITS AND SAFETY
Rapamune (sirolimus) helps protect the transplanted liver by lowering the immune activity that causes rejection. It may also reduce reliance on calcineurin inhibitors, and it is taken as a convenient once-daily oral regimen. The benefit varies from person to person, depending on your transplant, your other medications, and how your body responds. Rapamune works best as part of a personalized care plan with regular blood tests and follow-up visits.
As with any medication, Rapamune may cause side effects. Common ones include raised cholesterol or triglycerides, mouth sores, swelling of the legs or ankles, a higher risk of infection, and delayed wound healing. Your transplant team will monitor you throughout treatment and adjust your care plan as needed to balance benefits against risks.
BENEFITS
Rapamune helps protect your transplanted liver from rejection. In daily life, that protection depends on steady medicine levels, so taking every dose as prescribed and keeping your laboratory appointments are what turn the benefit into results.
Many transplant regimens rely on calcineurin inhibitors, such as tacrolimus or cyclosporine. Rapamune may reduce the need to rely on these medicines, and your provider may use it in their place or alongside them. Your transplant team decides whether this approach fits your situation.
Rapamune is generally used for the long term and may continue for many years, or for life, if you tolerate it well and it remains appropriate. Over that time, regular checks of your sirolimus blood levels, liver function, and kidney function help your team adjust the plan to support transplant success.
Rapamune is a convenient oral regimen that you take once a day, as a tablet or an oral solution. You can take it with or without food, and a steady daily routine at the same time each day makes it easier to fit into your life.
Your transplant team will discuss the potential benefits and risks before treatment and provide ongoing support, including regular blood tests, to help ensure safe use. Report any side effects to your transplant team.
SUPPORTING YOUR RESULTS
Rapamune should be used together with healthy daily habits that protect you and your transplanted liver. Taking it consistently, guarding against infection and sun exposure, and keeping your appointments all help your transplant team keep your treatment on track.
These habits support medication safety and the health of your transplanted liver over time.
Areas that may support treatment:
Common questions
Rapamune (Sirolimus) may be considered for people who have received a liver transplant and need long-term immunosuppressive therapy. Your provider may also choose it as an alternative or add-on to calcineurin inhibitors, or when they want to lower the risk of rejection with a plan tailored to you. Because every health profile is different, your transplant team decides after reviewing your transplant, your other medications, and your test results.
Rapamune blocks the mTOR pathway, a signal that activates immune cells. With that pathway blocked, T-cells cannot multiply as they normally would, so fewer are available to attack the new liver. This reduces immune-mediated injury and helps prevent both acute and chronic rejection. Your transplant team checks your sirolimus blood levels and your response over time to see how well it works for you.
Take Rapamune by mouth once daily, at the same time each day, with or without food. It comes as tablets or an oral solution. Keep the same routine so your blood levels stay steady, and do not miss doses. Your transplant team adjusts your dose based on sirolimus blood levels, so never change it on your own.
Rapamune is generally used as long-term maintenance therapy, so you may take it for many years or for life. Treatment continues if you tolerate it well and it remains clinically appropriate. Your transplant team adjusts your dose from time to time based on blood drug levels, transplant stability, and your overall immunosuppressive needs. Do not stop taking Rapamune without talking to your transplant team first.
Common Rapamune side effects include raised cholesterol or triglycerides, mouth sores, swelling of the legs or ankles, a higher risk of infection, and delayed wound healing. Your transplant team monitors your sirolimus blood levels, liver function, kidney function, cholesterol levels, and blood counts to help catch problems early. Report any symptoms to your team, who can help you weigh the benefits against the risks.
Avoid grapefruit products unless your healthcare provider approves them, because they can significantly change sirolimus blood levels. Also avoid live vaccines unless your transplant team approves them. Practice good hand hygiene to lower infection risk, and use sunscreen and protective clothing to reduce skin cancer risk. Attend all follow-up visits and lab tests, and ask your transplant team about anything else that concerns you.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
